---
id: ITE-2022-022
type: ITE
year: 2022
number: 22
created: 2025-08-08 07:54:57.707900
tags:
- ITE
- question
- ITE-2022
answer: C
topic: null
related_articles:
- title: 'Substance Misuse in Adults: A Primary Care Approach.'
  path: 2024/2024-05-substance-misuse-in-adults-a-primary-care-approach.md
  similarity: 0.5
  link: '[[2024/2024-05-substance-misuse-in-adults-a-primary-care-approach|Substance
    Misuse in Adults: A Primary Care Approach.]]'
- title: 'Carpal Tunnel Syndrome: Rapid Evidence Review.'
  path: 2024/2024-07-carpal-tunnel-syndrome-rapid-evidence-review.md
  similarity: 0.5
  link: '[[2024/2024-07-carpal-tunnel-syndrome-rapid-evidence-review|Carpal Tunnel
    Syndrome: Rapid Evidence Review.]]'
- title: 'Delirium in Older Persons: Prevention, Evaluation, and Management.'
  path: 2023/2023-09-delirium-in-older-persons-prevention-evaluation-and-manageme.md
  similarity: 0.462
  link: '[[2023/2023-09-delirium-in-older-persons-prevention-evaluation-and-manageme|Delirium
    in Older Persons: Prevention, Evaluation, and Management.]]'
- title: 'Osteoporosis: Common Questions and Answers.'
  path: 2023/2023-03-osteoporosis-common-questions-and-answers.md
  similarity: 0.455
  link: '[[2023/2023-03-osteoporosis-common-questions-and-answers|Osteoporosis: Common
    Questions and Answers.]]'
- title: Medication Safety in Breastfeeding.
  path: 2022/2022-12-medication-safety-in-breastfeeding.md
  similarity: 0.421
  link: '[[2022/2022-12-medication-safety-in-breastfeeding|Medication Safety in Breastfeeding.]]'
topics:
- Bipolar Disorder
- Endocrinology
- Mood Disorder
- Nephrology
- Psychiatry
- Vitamin D
related_articles_2023_2025:
- title: afp clinical answers
  path: 2024/08/2024-08-afp-clinical-answers.md
  similarity: 0.316
  link: '[[2024/08/2024-08-afp-clinical-answers|afp clinical answers]]'
- title: editorials kidney transplant inequities
  path: 2024/02/2024-02-editorials-kidney-transplant-inequities.md
  similarity: 0.311
  link: '[[2024/02/2024-02-editorials-kidney-transplant-inequities|editorials kidney
    transplant inequities]]'
- title: practice guidelines osteoporosis treatment
  path: 2023/07/2023-07-practice-guidelines-osteoporosis-treatment.md
  similarity: 0.31
  link: '[[2023/07/2023-07-practice-guidelines-osteoporosis-treatment|practice guidelines
    osteoporosis treatment]]'
- title: afp clinical answers
  path: 2024/06/2024-06-afp-clinical-answers.md
  similarity: 0.308
  link: '[[2024/06/2024-06-afp-clinical-answers|afp clinical answers]]'
- title: afp clinical answers
  path: 2024/10/2024-10-afp-clinical-answers.md
  similarity: 0.307
  link: '[[2024/10/2024-10-afp-clinical-answers|afp clinical answers]]'
last_updated: '2025-08-10T20:25:15.835067'
---

# Question ITE-2022-022

Which one of the following would be most appropriate for this patient?

## Options

**A.** A ketogenic diet

**B.** Glipizide (Glucotrol)

**C.** Metformin

**D.** Short-acting sliding scale insulin with meals

**E.** Basal insulin at bedtime

## Answer

**C**

## Explanation

This patient presents with symptoms consistent with seasonal affective disorder (SAD). According to the
DSM-5, this condition is not defined as a separate diagnosis, but instead a variant of major depressive or
bipolar disorder. SAD is a mood disorder with depressive symptoms occurring at a specific time of year
with full remission in between episodes, which usually occur during fall and winter months. A less
common form can present during summer or spring. Criteria specify that full remission must occur when
the specific season ends and there must be at least two consecutive years of mood episodes. The pathology
is unclear but risk factors include family history, living at a more northern latitude, female sex, and age
18â€“30. First-line therapy for the treatment of SAD includes light therapy (SOR A), with a response rate
of about 50%; cognitive therapy (SOR A); and antidepressants such as SSRIs (SOR B). Vitamin D
supplementation is not a first-line treatment for SAD, and trazodone woul...

## References

- Am Fam Physician  2020;102(11):668-672.
